Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/08/2012CA2809679A1 Phosphonate ester derivatives and methods of synthesis thereof
03/08/2012CA2809666A1 Dry powder formulations and methods for treating pulmonary diseases
03/08/2012CA2809662A1 Pyridazinones, method of making, and method of use thereof
03/08/2012CA2809637A1 Antisense nucleic acids
03/08/2012CA2809553A1 Imidazo[4,5-c]quinolines as dna-pk inhibitors
03/08/2012CA2809535A1 Antifungal composition
03/08/2012CA2809439A1 Novel single chemical entities and methods for delivery of oligonucleotides
03/08/2012CA2809391A1 4-{[(pyridin-3-yl-methyl)aminocarbonyl]amino}benzene-sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer
03/08/2012CA2809374A1 Composition and method for muscle repair and regeneration
03/08/2012CA2809222A1 Bace inhibitors for use in the treatment of diabetes
03/08/2012CA2809194A1 Kinases as targets for anti-diabetic therapy
03/08/2012CA2809178A1 Tyrosine kinase inhibitors
03/08/2012CA2809112A1 Cyclic amide derivative
03/08/2012CA2808912A1 Modified-release dosage forms of 5-ht2c agonists useful for weight management
03/08/2012CA2808909A1 Salts of lorcaserin with optically active acids
03/08/2012CA2808908A1 Combination of hdac inhibitors with thrombocytopenia drugs
03/08/2012CA2808900A1 Fast-dissolve dosage forms of 5-ht2c agonists
03/08/2012CA2808890A1 Administration of lorcaserin to individuals with renal impairment
03/08/2012CA2808731A1 Crystalline forms of maraviroc phosphate and process for maraviroc amorphous form
03/08/2012CA2808237A1 High dose buprenorphine compositions and use as analgesic
03/08/2012CA2808234A1 Pesticidal compositions
03/08/2012CA2808230A1 Process for producing 1-triazole-2-butanol derivatives
03/08/2012CA2808170A1 Mesalazine tablet having improved dissolution
03/08/2012CA2808144A1 Pest control agent
03/08/2012CA2807886A1 Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators
03/08/2012CA2807620A1 Pharmaceutically active compounds as axl inhibitors
03/08/2012CA2806647A1 5-ht2b receptor antagonists
03/08/2012CA2806273A1 Pure erlotinib
03/08/2012CA2806238A1 Methods for treating neurodegenerative diseases
03/08/2012CA2806103A1 Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of mglur5 receptors
03/07/2012EP2426208A1 Methods for genetic control of insect infestations in plants and compositions thereof
03/07/2012EP2426203A2 Agents useful in treating facioscapulohumeral muscular dystrophy
03/07/2012EP2426202A1 Kinases as targets for anti-diabetic therapy
03/07/2012EP2426135A1 Urea derivative having pi3k inhibitory activity
03/07/2012EP2426134A2 Method of modulating stress-activated protein kinase system
03/07/2012EP2426132A1 Process for preparing 14-hydroxycodeinone from thebaine
03/07/2012EP2426130A1 Purine derivative and antitumor agent using same
03/07/2012EP2426129A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
03/07/2012EP2426128A1 Carbostyril compound
03/07/2012EP2426126A1 Method for producing olmesartan medoxomil
03/07/2012EP2426125A1 1,4 disubstituted 3 cyano pyridone derivatives and their use as positive allosteric modulators of mGluR2 receptors
03/07/2012EP2426122A1 Methylene urea derivative as RAF kinasse inhibitors
03/07/2012EP2426121A1 Quaternary ammonium salt compound
03/07/2012EP2426118A1 Methods of making the polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/07/2012EP2426117A1 Thiophene derivative
03/07/2012EP2426115A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/07/2012EP2426113A1 Carbinol compound having heterocyclic linker
03/07/2012EP2426112A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
03/07/2012EP2426111A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms
03/07/2012EP2426109A1 Novel kinase inhibitors
03/07/2012EP2426106A1 Piperidine and Piperazine derivatives for the treatment of tumours
03/07/2012EP2425874A2 Use of a vitamin D compound and an additional therapeutic agent for the treatment of cancer
03/07/2012EP2425859A1 Olmesartan formulations
03/07/2012EP2425858A2 Compositions for treating pain and pruritus
03/07/2012EP2425857A1 Antiparasitic agent for fish and method of controlling proliferation of fish parasites
03/07/2012EP2425849A2 Compositions and methods using anti-CS1 antibodies to treat multiple myeloma
03/07/2012EP2425846A1 Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
03/07/2012EP2425845A1 Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease
03/07/2012EP2425841A1 Methods Employing and Compositions Containing Defined Oxidized Phospholipids for Prevention and Treatment of Atherosclerosis
03/07/2012EP2425840A1 Triazine derivatives and their therapeutical applications
03/07/2012EP2425839A1 Method for treatment of diseases
03/07/2012EP2425838A2 Combination therapy for treatment of immune disorders
03/07/2012EP2425837A1 Use of cell autophagy (type ii cell apoptosis) inhibitors
03/07/2012EP2425836A1 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/07/2012EP2425835A1 A new medical use of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate and natural flavonoid derivatives
03/07/2012EP2425834A1 Process for the production of l-carnitine tartrate
03/07/2012EP2425833A1 Intravenous application of fish oils / DHA + EPA before or at the beginning of chemotherapy
03/07/2012EP2425832A1 Tormentic acid for the treatment of skin disorders
03/07/2012EP2425831A1 Scca-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient
03/07/2012EP2425830A1 Synergistic drug combination for the treatment of cancer
03/07/2012EP2425829A1 Soluble pharmaceutical forms of n,n'-diaminodiphenyl sulphone for optimum use in the treatment of various diseases
03/07/2012EP2425828A2 Films for delivery of a therapeutic agent
03/07/2012EP2425827A1 Transdermal preparation
03/07/2012EP2425826A1 Mesalazine tablet having improved dissolution
03/07/2012EP2425825A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425824A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425823A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425822A1 Sustained release tablets with hydromorphone
03/07/2012EP2425821A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425820A1 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
03/07/2012EP2425819A1 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
03/07/2012EP2425818A1 Self micro-emulsifying oral pharmaceutical composition of hydrophilic drug and preparation method thereof
03/07/2012EP2425815A1 Stabilized pharmaceutical sub-micron suspensions and methods of forming same
03/07/2012EP2425722A2 Drugs and food products for hypophosphoric normo-, hyper- and hypoproteic diets, and hypophosphoric beverages
03/07/2012EP2425715A1 Treating symptoms of renal disease with selective androgen receptor modulators (SARM)
03/07/2012EP2425016A2 Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure
03/07/2012EP2425013A1 Serotonin transporter gene and treatment of alcoholism
03/07/2012EP2424991A1 Gene therapy for neurodegenerative disorders
03/07/2012EP2424988A1 Concatamers for immunemodulation
03/07/2012EP2424987A2 Antisense oligonucleotides of hemoglobins
03/07/2012EP2424985A1 Hepcidin binding nucleic acids
03/07/2012EP2424874A1 Novel phosphate modified nucleosides useful as substrates for polymerases and as antiviral angents
03/07/2012EP2424873A1 Novel galactoside inhibitors of galectins
03/07/2012EP2424872A1 Neuroprotective compounds and their use
03/07/2012EP2424870A1 Therapeutic agents 713
03/07/2012EP2424869A1 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
03/07/2012EP2424868A1 Cdk inhibitor salts
03/07/2012EP2424867A1 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine derivatives as p2x7 modulators
03/07/2012EP2424866A1 Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as -secretase inhibitors
03/07/2012EP2424865A2 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
1 ... 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 ... 7860